Publications by authors named "Evan Lind"

Claim this Profile
T
The aryl hydrocarbon receptor is associated with monocytic AML and innate immune resistance reversible with an AHR inhibitor.
Jennifer N Saultz, Daniel Bottomly, Faith Burns, Kaelan Byrd, Yoko Kosaka, Evan F Lind

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase.
Danny V Jeyaraju, Maryam Alapa, Ann Polonskaia, Alberto Risueño, Prakash Subramanyam, Evan F Lind

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Patrick A Flynn, Mark D Long, Yoko Kosaka, Nicola Long, Jessica S Mulkey, Evan F Lind

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, Evan Lind

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Patrick A Flynn, Mark D Long, Yoko Kosaka, Jessica S Mulkey, Jesse L Coy, Evan F Lind

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 T cells.
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Evan F Lind

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Daniel Bottomly, Nicola Long, Anna Reister Schultz, Stephen E Kurtz, Cristina E Tognon, Evan F Lind

Cancer Cell· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.
Jessica T Leonard, Yoko Kosaka, Pavani Malla, Dorian LaTocha, Adam Lamble, Evan Lind

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.
Scott Best, Vi Lam, Tingting Liu, Nur Bruss, Adam Kittai, Evan F Lind

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Adam J Lamble, Yoko Kosaka, Ted Laderas, Allie Maffit, Andy Kaempf, Evan F Lind

Proc Natl Acad Sci U S A· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway.
Kaycee B Moshofsky, Hyun J Cho, Guanming Wu, Kyle A Romine, Matthew T Newman, Evan F Lind

Blood Adv· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
David K Edwards, Kevin Watanabe-Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Evan F Lind

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.
Haijiao Zhang, Samantha Savage, Anna Reister Schultz, Daniel Bottomly, Libbey White, Evan Lind

Nat Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timed Regulation of 3BP2 Induction Is Critical for Sustaining CD8 T Cell Expansion and Differentiation.
Ioannis D Dimitriou, Korris Lee, Itoro Akpan, Evan F Lind, Valarie A Barr

Cell Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.
Adam J Lamble, Evan F Lind

Front Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.
Adam J Lamble, Matthew Dietz, Ted Laderas, Shannon McWeeney, Evan F Lind

J Immunol Methods· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.
Satoshi Inoue, Wanda Y Li, Alan Tseng, Isabel Beerman, Andrew J Elia, Evan F Lind

Cancer Cell· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1.
Evan F Lind, Douglas G Millar, Dilan Dissanayake, Jonathan C Savage, Natasha K Grimshaw

J Immunol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mir-155, a central modulator of T-cell responses.
Evan F Lind, Pamela S Ohashi

Eur J Immunol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges.
Evan F Lind, Alisha R Elford, Pamela S Ohashi

J Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells.
Samit Chatterjee, Laurie Seifried, Michael E Feigin, Don L Gibbons, Claudio Scuoppo, Evan Lind

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.
Masato Sasaki, Christiane B Knobbe, Joshua C Munger, Evan F Lind, Dirk Brenner

Nature· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.
Miguel Quintela-Fandino, Enrico Arpaia, Dirk Brenner, Theo Goh, Faith Au Yeung, Evan F Lind

Proc Natl Acad Sci U S A· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.
Shintaro Kamizono, Gordon S Duncan, Markus G Seidel, Akira Morimoto, Koichi Hamada, Evan F Lind

J Exp Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens.
Evan F Lind, Cory L Ahonen, Anna Wasiuk, Yoko Kosaka, Burkhard Becher

J Immunol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis